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Abstract—Background: Multifractal analysis of human 
heartbeat dynamics has been demonstrated to provide 
promising markers of congestive heart failure (CHF). Yet, 
it crucially builds on the interpolation of RR interval se-
ries which has been generically performed with limited 
links to CHF pathophysiology. Objective: We devise a novel 
methodology estimating multifractal autonomic dynamics 
from heartbeat-derived series defined in the continuous 
time. We hypothesize that markers estimated from our 
novel framework are also effective for mortality predic-
tion in severe CHF. Methods: We merge multifractal anal-
ysis within a methodological framework based on inho-
mogeneous point process models of heartbeat dynamics. 
Specifically, wavelet coefficients and wavelet leaders are 
computed over measures extracted from instantaneous 
statistics of probability density functions characterizing and 
predicting the time until the next heartbeat event occurs. 
The proposed approach is tested on data from 94 CHF pa-
tients aiming at predicting survivor and nonsurvivor individ-
uals as determined after a four years follow up. Results and 
Discussion: Instantaneous markers of vagal and sympatho-
vagal dynamics display power-law scaling for a large range 
of scales, from ≃0.5 to ≃100 s. Using standard support 
vector machine algorithms, the proposed inhomogeneous 
point-process representation-based multifractal analysis 
achieved the best CHF mortality prediction accuracy of 
79.11% (sensitivity 90.48%, specificity 67.74%). Conclusion: 
Our results suggest that heartbeat scaling and multifractal 
properties in CHF patients are not generated at the sinus-
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node level, but rather by the intrinsic action of vagal short-
term control and of sympatho-vagal fluctuations 
associated with circadian cardiovascular control especially 
within the very low frequency band. These markers might 
provide crit-ical information in devising a clinical tool for 
individualized prediction of survivor and nonsurvivor CHF 
patients.
Index Terms—Multifractal analysis, point process, heart 
rate variability, wavelet coefficients, wavelet leaders, con-
gestive heart failure, autonomic nervous system.
I. INTRODUCTION
NONLINEAR dynamics of human cardiovascular oscilla-tions has long been recognized throughout the past two
decades [1]–[3]. In fact, because of the multiple dynamical
interplay with other physiological systems (e.g., endocrine,
neural, and respiratory), as well as multiple biochemical pro-
cesses, combined sympathetic and vagal stimulations on heart
rate control are not simply additive [1]. Consequently, stan-
dard estimates from heartbeat dynamics defined in the time
and frequency domains [4], which intrinsically assume that
the magnitude of cardiac responses is proportional to the
strength/amplitude of the autonomic stimuli, need complemen-
tary nonlinear/multiscale metrics (see [2], [4]–[6] and references
therein for reviews). Among others, fractal theory has been giv-
ing a major contribution in understanding complex cardiovascu-
lar dynamics especially involving nonlinear cardiovascular con-
trol and related autonomic nervous system (ANS) activity [2],
[5], [7]–[11]. Recently, a robust and efficient procedure relying
on the use of multiscale representation and wavelet leaders, has
been proposed to conduct multifractal analysis [10] and tested
on heartbeat series [8], [11].
A paradigmatic clinical application of these metrics refers to
severe congestive heart failure (CHF) [9], [12]. Indeed, non-
linear measures derived from bispectral, entropy, and non-
Gaussian analyses have been proven effective in discerning
healthy subjects from CHF patients at a group-wise level [2],
[4], [5], [12]–[17]. Also in CHF patients, departures from Gaus-
sianity were used to evaluate increased mortality risk [9], and
compared against fractal exponent [18]. Leveraging on the so-
called cardiovascular fractal complexity at many spatial and
temporal scales, multifractal analyses were successfully em-
ployed to model ANS regulatory actions and related temporal
fluctuations in CHF heartbeat dynamics [2], [4], [5], [19], [20].
Additionally, in discerning the healthy from CHF patients, Dutta
[21] reported on the dependency of parameters on multifractal
spectra, whereas Galaska et al. [22] pointed on advantages of
multifractal detrended fluctuation analysis.
Nevertheless, several limitations can be pointed out in deal-
ing with current multiscale approaches: i) the intrinsic discrete
nature of the unevenly sampled R-R interval series can lead to
estimation errors; considering the series as inter-events does not
allow for matching time scales, and may be missing intrinsic
generative properties as reflected in complex dynamics; ii) the
application of preliminary interpolation procedures could affect
complexity estimates, with a bias from the specific interpolation
function (e.g., linear, polynomial, etc.); iii) multifractal analysis
has always been performed over series of heartbeat dynamics ex-
clusively; therefore it is unknown whether scale-free properties
arise from the nonlinear/complex interactions between sympa-
thetic and parasympathetic activity at the level of the sinoatrial
node (as thoroughly reported in [1]), or whether there are already
intrinsic multifractal properties in each autonomic dynamics per
se; iv) specifically for CHF, an effective prediction of mortality
risk, as well as risk stratification, at a single-subject level with
enough accuracy for a direct application in clinical practice [9],
[11], [23], [24] is still missing.
To overcome these limitations, in this study we propose a
novel methodology combining multifractal analysis and inho-
mogeneous point-process models, which have been specifically
devised for cardiovascular dynamics [14], [25]. Specifically,
we propose multiscale representation and the so-called wavelet
p-leaders, i.e., local ℓp norms of wavelet coefficients [10], [26]
of moments derived from probability density functions (PDFs)
characterizing and predicting the time until the next heartbeat
event occurs. To this extent, we proposed the use of inhomo-
geneous point-processes to effectively characterize the proba-
bilistic generative mechanism of heartbeat events, even con-
sidering short recordings under nonstationary conditions [25].
The unevenly spaced heartbeat intervals are then represented
as multiscale quantities of a state-space point process model
defined at each moment in time, thus allowing to estimate in-
stantaneous measures without using any interpolation method,
therefore overcoming limitations i) and ii). We demonstrate how
to capture fluctuations of regularity in heartbeat data by scan-
ning all details finer than the chosen analysis scale [8], [11]. To
compare our method against a more standard approach, we also
investigate the use of a non-informative standard spline-based
interpolation. Finally, we here study multiscale properties of
heartbeat-derived series with high resolution in time, including
long-term instantaneous mean heart rate, standard deviation, and
low-frequency (LF) and high-frequency (HF) spectral powers,
which correspond to time-varying vagal activity estimates [4],
thus overcoming limitation iii). Application of these metrics is
then performed on experimental data gathered from 94 CHF
patients by evaluating the recognition accuracy in predicting
survivor and non-survivor patients after a 4 years follow up,
demonstrating how to overcome limitation iv). Of note, prelim-
inary results associated with this study were presented in [27],
[28], in which a wavelet leader-based multiscale representation
was applied to instantaneous heartbeat series as well as to in-
stantaneous vagal activity series. Here, we significantly expand
on these results by generalizing the development of the method-
ology to be suitable for generic inhomogeneous point process-
derived heartbeat dynamics series defined in continuous time, as
well as by increasing the number of patients involved in the ex-
periment, and accounting for their clinical characteristics. Fur-
thermore, the scale dependent features resulting from the pro-
posed methodology have been exploited through nonlinear sup-
port vector machines and related feature selection procedures.
II. MATERIALS AND METHODS
In this Section, we provide theoretical and methodological de-
tails on the proposed multifractal approach for inhomogeneous
point-processes of heartbeat dynamics. The overall processing
chain is shown in Fig. 1. Specifically, automatic R-peak detec-
tion is performed on artifact-free ECG series from each CHF
patient enrolled in this study. Recognition and correction of
eventual algorithmic (e.g., R-peak mis-detection) and/or physio-
logical artifacts (e.g., ectopic beats) was performed through our
recently proposed log-likelihood point process-based method
[29]. Then, for each RR interval series from each subject, a
continuous PDF in time, in the form of inverse-Gaussian dis-
tribution, is estimated for each heartbeat event considering the
long-term past events. From such continuous PDFs, multiscale
representations of a number of instantaneous estimates defined
in the time (e.g., mean heart rate and standard deviation) and fre-
quency domains (e.g., LF and HF powers) are derived. Finally,
these and further features are fed into a standard Support Vector
Machine (SVM) to predict mortality in CHF patients at a single-
Fig. 1. Overall data processing chain.
subject level. Validation was performed through a leave-one-out
procedure. Mathematical details of each processing stage follow
below.
A. Experimental Data
24-hour Holter ECG recordings from a cohort of 94 patients
suffering from CHF were made available by the Fujita Health
University Hospital, Japan. Of these patients, 31 died within
33 ± 17 months (range, 1–49 months) after hospital discharge,
whereas 61 survived for a longer time. The former group is re-
ferred to as non-survivors (NS) and the latter as survivors (SV).
Further clinical details can be found in [9]. For each patient, R
peak arrival times were carefully extracted from 24-hour Holter
ECG recordings. Missing data and outliers stemming from atrial
or ventricular premature complexes were handled by our pre-
processing automated tools [29]. All RR interval series were
also checked by visual inspection analysis. Subjects with sus-
tained tachyarrhythmias were excluded from the study. Baseline
clinical characteristics of the patients enrolled in this study are
shown in Table I. The study was approved by the ethics commit-
tee of Fujita Health University and conformed to the principles
outlined in the Declaration of Helsinki. All patients provided
written informed consent.
B. Multiscale Analysis
1) Self-Similarity and Wavelets: Classical multiscale anal-
ysis relies on the estimation of wavelet coefficients, which are
obtained by comparing the cumulated sum of a series of RR inter-
vals {R R} to the collection {ψ j,k(t) = 2− jψ(2− j t − k)}( j,k)∈N2
of dilated and translated templates of a mother wavelet ψ via
inner products, d{R R}( j, k) = 〈ψ j,k |{R R}〉 (see, e.g., [30] for
details on wavelet transforms).
For self-similar processes {R R} such as fractional Brownian
motion, which are commonly used models for heartbeat dynam-
ics series [19], the so-called wavelet structure functions S(q, j)
display power laws with respect to scale j and order of sample
TABLE I
BASELINE CLINICAL CHARACTERISTICS OF THE PATIENTS
Survivors (n = 63) Non Survivors (n = 31) p-val
Age [years] 66.5 ± 10 71 ± 8 >0.05
Sex [M/F] 39/24 17/14 >0.05
NYHA:
class II 9(15.5%) 3(9.7%) >0.05
class III–IV 54(84.5%) 28(90.3%) >0.05
Ischemia 15 (25.8%) 15(48.4%) <0.05
LVEF [%] 36.5 ± 11.5 40 ± 10 >0.05
BNP [pg/mL] 483.5 ± 322.5 960.0 ± 490.0 <0.01
BUN [mg/dL] 18.5 ± 5.5 25.0 ± 8.0 <0.01
Cr [mg/dL] 0.8 ± 0.3 1.0 ± 0.4 <0.05
Beta-blocker 21(36.2%) 7(22.6%) >0.05
Hb 12.25 ± 1.25 10.9 ± 1.9 <0.05
ACE/ARB 25(43.1%) 16(51.6%) >0.05
Loop diuretic 26(44.8%) 21(67.8%) <0.05
Spironolactone 14(24.1%) 13(41.9%) <0.05
VPBh 1.062 ± 1.062 1.333 ± 1.333 >0.05
Uncorrected p-values calculated from Mann-Whitney Non-parametric tests for contin-
uous variables and Chi-square test for other variables.
NYHA: New York Heart Association functional class; LVEF: Left ventricular ejection
fraction; ACE: angiotensin-converting enzyme inhibitor; ARB: angiotensin II receptor
blocker; BNP: brain natriuretic peptide; BUN: blood urea nitrogen; Cr: creatinine; Hb:
Hemoglobin; VPBh: Ventricular premature beats per hour.
moments q:
S(q, j) =
n j∑
k=1
|d{R R}( j, k)|q ≃ Kq2 jq H (1)
with n j the number of d{R R}( j, k) available at scale 2 j . The
Hurst parameter H and the function S(q = 2, j) are directly
related to the distribution of energy along frequencies (i.e., to
the Fourier spectrum or autocorrelation of {R R}). They are
hence linear features of {R R} that can be efficiently estimated
using wavelets [8], [10].
2) Multifractal Models and Wavelet p-Leaders: It has
been demonstrated that self-similar models describe only parts
of the scaling properties in HRV data and that multifractal mod-
els could provide more complete descriptions (see, e.g., [2],
[8]). These models essentially imply that the linear scaling ex-
ponents q H in (3) should be replaced with a more flexible,
concave function ζ (q), and that the parameter H alone can no
longer account for all scaling properties in HRV data. To cor-
rectly estimate ζ (q), wavelet coefficients must be replaced with
non-linear multiscale quantities that sense the local regularity
fluctuations in data across all finer scales [10]. In this study, we
employ the wavelet p-leaders, which have recently renewed the
state-of-the-art for the estimation of multifractal models [26],
for the primitive {R R}′(t) = ∫ t {R R}(s)ds of {R R}. They are
defined as ℓp-norms, computed in a narrow time neighborhood
over all finer scales, of the wavelet coefficients of {R R}′,
L (p){R R}′ ( j, k) =
(
2 j
∑
λ′⊂3λ j,k
|d{R R}′ (λ′)|p2− j ′
)1/p
, (2)
with λ j,k = [k2 j , (k + 1)2 j ) and 3λ j,k =
⋃
m∈{−1,0,1} λ j,k+m .
The parameter p > 0 must be chosen to ensure minimal reg-
ularity constraints (cf. [26] and references therein for details
on multifractal analysis, beyond the scope of this contribution).
Below, we use p = 1, which have been shown to yield lowest
variance [26]. it has been shown that the multifractal proper-
ties of {R R} are well described by a multiscale representation
consisting of the sample cumulants Cumm of the logarithm of
p-leaders ln L (p){R R}′ ( j, ·) [10]
Cm( j) ≡ Cumm ln L (p){R R}′( j) ≃ c0m + cm ln 2 j . (3)
In particular, the coefficients cm are related to ζ (q) via the
polynomial expansion ζ (q) ≡∑m≥1 cmqm/m! (and hence to
the multifractal spectrum, cf., [10] for details). Consequently,
the leading coefficients c1 and C1( j) are closely related to H
and S(2, j), respectively, and constitute linear features associ-
ated to the autocorrelation of {R R} [8], [10], while C2( j), C3( j)
and C4( j) (the variance, skewness and kurtosis of ln L (p){R R}′( j),
respectively) and c2, c3 and c4 (related to the multifractal prop-
erties of {R R}) are nonlinear features that capture information
beyond correlation.
C. Instantaneous Autonomic Features for Multifractals
1) Point Process Models: We model the unevenly sampled
RR interval series through inverse-Gaussian PDFs whose first-
order moment (the meanµR R(t,Ht , ξ (t)), withHt as the history
of past RR intervals, ξ (t) the vector of the time-varying param-
eters, and ξ0(t) the shape parameters of the inverse-Gaussian)
has an autoregressive formulation. Importantly, the use of an
inverse Gaussian distribution f (t |Ht , ξ (t)) is physiologically
motivated, as it models the integrate-and-fire mechanism of the
cardiac contraction [25]).
The inverse Gaussian is defined as:
f (t |Ht , ξ (t)) =
[
ξ0(t)
2π (t − u j )3
] 1
2
× exp
{
−
1
2
ξ0(t)[t − u j − µ(t,Ht , ξ (t))]2
µ(t,Ht , ξ (t))2(t − u j )
}
(4)
with j = N˜ (t) the index of the previous R-wave event before
time t , and:
µR R(t,Ht , ξ (t)) = γ0 +
p∑
i=1
γ1(i, t) R R N˜ (t)−i (5)
where Ht = (u j , R R j , R R j−1, ..., R R j−p+1), ξ (t) = [ξ0(t),
γ0(t), γ1(1, t), ..., γ1(p, t)], and ξ0(t) > 0.
Since these PDFs are defined at each moment in time, it is
possible to obtain an instantaneous estimate of µR R(t) at a very
fine time scale (with an arbitrarily small bin size 1), which re-
quires no interpolation between the arrival times of two beats,
therefore addressing the problem of dealing with unevenly sam-
pled observations. This key advantage, particularly useful when
dealing with multifractality, applies also for the derivation of
spectral measures, following the estimation of µR R(t,Ht , ξ (t)).
2) Model Identification: We estimate the parameter vectors
ξ (t) at each time interval 1 = 5 ms using a Newton-Raphson
procedure to compute the local maximum-likelihood estimate
[25] using observations within a time window of 90 s. Because
there is significant overlap between adjacent local likelihood
intervals, we start the Newton-Raphson procedure at t with
the previous local maximum-likelihood estimate at time t −1,
where 1 defines the time interval shift to compute the next
parameter update. We determine the optimal model order {p} by
pre-fitting the point process model to a subset of the data. Model
goodness-of-fit is based on the Kolmogorov-Smirnov (KS) test
and associated KS statistics. The recursive, causal nature of the
estimation allows to predict each new observation, given the
previous history independently at each iteration. The model and
all its parameters are therefore also updated at each iteration,
without priors. In other words, each test point R Rk is tested
against one instance of a time-varying model trained with points
{R R j } with j < k. Autocorrelation plots are also considered to
test the independence of the model-transformed intervals. Once
the order {p} is determined, the initial model coefficients are
estimated by the method of least squares. Extensive details on
all these steps can be found in [25].
3) Feature Selection: Our framework allows for a
quantitative characterization of autonomic features based
on instantaneous time- and frequency-domain estimations.
Time-domain indices are based on the first and the second order
moments of the underlying probability structure. Namely, given
the time-varying parameter set ξ (t), the instantaneous estimates
of mean µR R(t,Ht , ξ (t)), R-R interval standard deviation
σ 2R R(t,Ht , ξ (t)), mean heart rate µH R(t,Ht , ξ (t)), and heart
rate standard deviation σH R(t,Ht , ξ (t)) can be derived at each
moment in time as follows [14], [25]:
σ 2R R(t,Ht , ξ (t)) = µ3R R(t)/ξ0(t). (6)
µH R(t,Ht ,ξ (t)) = ˜µR R
−1 + ξ0(t)−1 (7)
σH R(t,Ht , ξ (t)) =
[
2 ˜µR R + ξ0(t)
˜µR R ξ0
2(t)
]1/2
(8)
Linear power spectrum estimation allows for selection of
autonomic features in the frequency domain. In particular, given
the model ofµR R(t,Ht , ξ (t)), we can compute the time-varying
parametric (linear) autospectrum [14], [25] as follows:
Q( f, t) = σ 2R R H1( f, t)H1(− f, t) (9)
where H1 represents the Fourier transform of the γ1 terms (see
(5)). By integrating (9) in each frequency band, we compute
the indices within the very low frequency (VLF = 0+−0.04
Hz), low frequency (LF = 0.04–0.15 Hz), and high fre-
quency (HF = 0.14–0.45 Hz) ranges, along with their ratio
(L F/H F). In the end, the instantaneous feature set consid-
ered for further analyses is as follows: µR R(t), ξ0(t), σ 2R R(t),
V L F(t), L F(t), H F(t), L F/H F(t). The information about
the long-term, time-varying dynamics of each given instanta-
neous feature can then be summarized using a subset of ex-
ponents ζ (2), c1, c2, c3, c4, estimated for each range of scales
j = 1, . . . , 8, as well as a subset of multiscale representation
log2 S(2, j),C1( j),C2( j),C3( j),C4( j) for j ∈ [ jm, jM ], esti-
mated for each range of scales j = 5, . . . , 19.
D. Statistical Testing and Pattern Recognition
First, from the heartbeat series, we investigated the scaling
properties and predictive value in the frame of CHF for: i) heart-
beat series as interpolated using the informative Point Process
model, i.e., µR R(t); ii) heartbeat series as interpolated using a
standard non informative Spline-based interpolation, referred to
as the Spline Interpolated time series.
The analysis is conducted using Daubechies3 wavelets.
As mentioned in Feature Selection, for each feature µR R(t),
ξ0(t), σ 2R R(t), V L F(t), L F(t), H F(t), L F/H F(t), we consid-
ered
r α set: a subset of exponents ζ (2), c1, c2, c3, c4, obtained
as local slopes estimated over 4 octaves centred at
{1.71, 3.41, 6.83, 13.7, 27.3, 54.6, 109.2, 218.5} s.
r β set: a subset of multiscale representation log2 S(2, j),
C1( j), C2( j), C3( j), C4( j) for dyadic scales 2 j ∈
[0.21, 3495] s.
We then evaluated between-group differences (NS vs. SV) for
every feature using bivariate non parametric statistics (Mann-
Whitney test) under the null hypothesis that the between-subject
medians of the two groups are equal.
Furthermore, we employed an automatic classification algo-
rithm based on well-known SVM in order to automatically dis-
cern NS vs. SV at a single subject level. To this extent, a multidi-
mensional point in a given feature set was considered an outlier
if z-scores associated to its dimensions were greater than 2.58
(i.e., p < 0.01). To assess the out-of-sample predictive accuracy
of the system, we adopted a Leave-One-Out (LOO) procedure
based on a SVM-based classifier. Specifically, we employed a
ν-SVM (ν = 0.5) with a sigmoid kernel function with γ = n−1,
where n is equal to the number of features. Within the LOO
scheme, the training set was normalized by subtracting the me-
dian value and dividing by the median absolute deviation over
each dimension. These values were then used to normalize the
example belonging to the test set. During the LOO procedure,
this normalization step was performed on each fold.
In order to optimize the number of features to be used for
the NS vs. SV classification and to provide meaningful infor-
mation for the physiopathology-related discussion of results,
we applied a support vector machine recursive feature elimina-
tion (SVM-RFE) procedure. Such a procedure was carried out
on the training set at each LOO fold. Then, the mode of all
ranks was considered for further analyses. Note that SVM-RFE
includes a correlation bias reduction strategy into the feature
elimination procedure [31]. All analyses were performed using
Matlab (MathWorks, Natick, Massachusetts, USA) v8.4 and
an additional toolbox for pattern recognition (LIBSVM [32]).
Classification results are summarized as balanced recognition
accuracy, sensitivity and specificity.
III. RESULTS
Between SV and NS patients, there were no significant differ-
ences with regard to age, sex, disease severity according to New
York Heart Association classification, left ventricular ejection
fraction, use of beta-blockers, angiotensin-converting enzyme
inhibitor, and number of ventricular premature beats per hour.
NS patients exhibited higher prevalence of ischemic events,
higher plasma brain natriuretic peptide, blood urea nitrogen,
and creatinine, lower hemoglobin, and were treated more fre-
quently with diuretics during Holter recording (see Table I).
Fig. 2. Multiscale representations for the 3 different data modeling, for
SV an NS subjects (median values ; the blue shaded areas indicate time
scales not directly available from raw RR intervals).
A. Comparison Between Multifractals of Point-Process
and Standard Interpolation
The wavelet coefficient-based representations log2 S(2, j)
and C1( j) (related to self-similarity) and p-leader based rep-
resentations C2( j),C3( j),C4( j) (quantifying multifractality)
for the informative point-process time series µR R(t), for non-
informative cubic spline interpolation time-series, as well as for
raw RR interval data R R, are shown in Fig. 2 as a function of
scale 2 j . Scales have been translated to physical units (seconds)
using the inverse of the central frequency of the wavelet. Be-
cause of the intrinsic ambiguity in the unevenly sampled raw RR
interval series, associated scales are qualitatively matched using
the average over RR inter-arrival times for all NS or SV subjects,
respectively. This enables us to compare multiscale representa-
tions obtained from each method, as functions of equivalent
scales, for NS and SV subjects. The blue shaded area indicates
the finer resolution time scales that cannot be assessed for the
raw RR interval data (for the mother wavelet used here, smaller
than ≃2 s).
Results clearly show that the multiscale representations for
the three time series are essentially identical at large time scales
(i.e., above ≃10 s), therefore not altering actual coarse time
scales. This is to be expected for the spline interpolation, and
validates the proposed physiologically-informative quantifica-
tion strategy.
The finer scales below ∼2 s do not exist for original R R
series but can be computed for the interpolated data. Important
differences between physiologically-informative point process-
derived heartbeat series and smooth deterministic spline in-
terpolated series are shown, confirming the difference in the
two approaches. For the finest two time scales of RR inter-
vals (∼2 − 10 s), the scaling behaviour is broken and departs
from that observed at intermediary ≥10 s. For these scales,
Fig. 3. Scaling and multifractal properties of physiologically-informative point process-derived series of heartbeat dynamics between SV and NS
patients with severe CHF. The blue shaded areas indicate time scales not directly available from raw RR intervals. The red shaded areas represent
scales for which statistically significant differences between SV and NS patients exist.
the spline interpolated time series show scaling in agreement
with coarser scales for the (linear) self-similar representations
log2 S(2, j), C1( j), but they suffer from the same drawback as
R R for C2( j),C3( j),C4( j).
In contrast, the physiologically-informative point-process
model leads to a clean continuation of the scaling behaviour
that is manifested at coarser scales for log2 S(2, j), C1( j) as
well as for the multifractal representations C2( j),C3( j),C4( j).
This is particularly striking for C4( j), for which scaling is con-
tinued to one order of magnitude finer times scales than what
can be observed on R R.
B. Scaling Properties Between CHF Survivors and
Non-Survivors
The favourable comparison of the observed scale invariance
properties for the informative point process-derived time-series
µR R(t) motivates a closer investigation of the scaling and mul-
tifractal properties of other instantaneous estimates provided by
this model. Since S(2, j) and C1( j) quantify essentially the same
information, we discard S(2, j) here and focus on the represen-
tations C1( j),C2( j),C3( j),C4( j) for the sake of conciseness.
Fig. 3 reports these representations (from top to bottom) for
the time series µRR(t), ξ0(t), σ 2R R(t), H F(t), L F(t), V L F(t),
L F/H F(t) (from left to right), as a function of scale. In ad-
dition, scales for which the difference between NS and SV is
significant (Wilcoxon rank-sum p-values below the value 0.05)
are shaded in red (uncorrected p-values). Results indicate that
the time series µR R(t), ξ0(t), σ 2R R(t), H F(t) display power law
scaling from ∼0.5 s to ∼82 s. These scaling properties are
observed both for the NS and SV groups. For ξ0(t), the shape
parameter of inverse-Gaussian PDFs, scale invariance appears
to be perturbed for scales ∼2 − 10 s. Within this interval, sig-
nificant discerning between SV and NS patients with CHF are
associated with multifractal representations C3( j),C4( j). This
is consistent with previous evidences reporting that parasympa-
thetic activity affects complexity at short and long time scales,
with maximum at precisely the range of scales ∼2 − 10 s [33].
A second, different scaling regime is observed for coarse
time scales beyond 82 s, yet is apparently non-informative for
CHF clinical application, because the multiscale representations
similarly converge for NS and SV. In contrast, the difference
between NS and SV are almost systematically significant for
finer scales for the multifractal representation C3( j),C4( j).
Importantly, such significant differences are not observed for
the original RR time series. Also, interestingly, for ξ0(t), these
scales with significant differences largely overlap with those
where scaling is observed to be perturbed.
For the time series V L F(t), L F(t) and L F/H F(t) of instan-
taneous spectral measures, scale invariance in form of power
laws is evidenced exclusively for scales larger than ∼100 s,
again both for NS and SV. This indicates that the scaling prop-
erties of combined (because of the overlap in the LF band)
instantaneous sympathetic and parasympathetic activities can
be considered a signature of slower physiological phenomena
than those observed for the other time series. This is consistent
with previous evidences reporting that sympathetic activity af-
fects complexity only at long time scales [33], constituting best
predictors of mortality following myocardial infarct or heart
failure (see [33] and references therein).
These observations suggest that it is meaningful to esti-
mate self-similar and multifractal exponents c1 and c2, c3, c4,
respectively, for scales faster than ∼82 s for the time series
µR R(t), ξ0(t), σ 2R R(t), H F(t). Results are reported in Table II, to-
gether with those obtained for R R for comparison with µR R(t).
The instantaneous time series µR R(t), ξ0(t), σ 2R R(t), σ 2H R(t),
H F(t) can be well described by a multifractal model since
cm 6= 0 for m ≥ 2, both for NS and SV.
As discussed above, µR R(t) and R R lead to similar results,
with the exception of c4 for which µR R(t) yields a reduction of
cross-subject variability by a factor 3 to 4. The time series ξ0(t),
σ 2R R(t) (and to a lesser extent H F(t)) are further characterized
by a long-range persistence type autocorrelation with c1 > 0.5.
TABLE II
SCALING AND MULTIFRACTAL EXPONENTS c1, c2, c3, c4 ESTIMATED OVER
SCALES [2.6, 81.9] S-MEDIAN (MED) AND MEDIAN ABSOLUTE DEVIATION
(MAD)-P-VALUES FROM MANN-WHITNEY TEST
RR NS: med (mad) SV: med (mad) p-value
c1 0.104 (0.164) 0.156 (0.171) 0.07
c2 −0.007 (0.049) 0.004 (0.054) 0.60
c3 0.007 (0.040) 0.003 (0.037) 0.68
c4 −0.045 (0.275) −0.030 (0.298) 0.33
µRR NS: med (mad) SV: med (mad) p-value
c1 0.147 (0.155) 0.200 (0.175) 0.11
c2 −0.027 (0.044) −0.019 (0.060) 0.74
c3 −0.019 (0.050) −0.007 (0.048) 0.76
c4 −0.068 (0.096) −0.030 (0.064) 0.04
ξ0 NS: med (mad) SV: med (mad) p-value
c1 0.766 (0.062) 0.744 (0.095) 0.35
c2 −0.192 (0.094) −0.133 (0.118) 0.05
c3 0.124 (0.254) 0.071 (0.207) 0.19
c4 −0.340 (0.773) −0.228 (0.423) 0.24
σ 2
RR
NS: med (mad) SV: med (mad) p-value
c1 0.773 (0.058) 0.732 (0.093) 0.36
c2 0.026 (0.120) −0.009 (0.098) 0.23
c3 0.016 (0.149) 0.033 (0.125) 0.91
c4 −0.109 (0.489) 0.015 (0.538) 0.33
σ 2
HR
NS: med (mad) SV: med (mad) p-value
c1 0.759 (0.066) 0.715 (0.096) 0.49
c2 0.016 (0.118) −0.008 (0.116) 0.24
c3 −0.017 (0.186) 0.025 (0.164) 0.71
c4 −0.155 (0.876) −0.008 (0.705) 0.23
H F NS: med (mad) SV: med (mad) p-value
c1 0.549 (0.074) 0.526 (0.105) 0.88
c2 −0.164 (0.122) −0.197 (0.130) 0.19
c3 −0.137 (0.243) −0.080 (0.252) 0.82
c4 −0.611 (0.883) −0.488 (1.449) 0.35
Yet, none of the exponents cm , considered individually, can be
directly translated into the clinical practice for risk stratification
between NS and SV. Consistently with the fact that autonomic
nervous system linear and nonlinear dynamics cannot be fully
explained by a single measure only, in the next paragraph we
show how to combine the aforementioned multifractal point-
process measures for SV vs. NS discrimination in CHF at a
single subject level.
C. SV Versus NS Classification
Leveraging on the aforementioned results performed at a
group-wise level and with inferential significance only, we
moved beyond statistical analysis to automatically discern SV
from NS patients with CHF at a single-subject level. Scaling and
multifractal features of point process-derived heartbeat dynam-
ics are then combined throughout a nonlinear discriminant func-
tion, allowing therefore for a direct clinical translation. Follow-
ing the methodology description, we considered instantaneous
dynamics of µR R(t), ξ0(t), σ 2R R(t), σ 2H R(t), V L F(t), L F(t),
H F(t), L F/H F(t), and condensed the information about the
long-term, time-varying dynamics using the α and β sets of ex-
ponents and multiscale representations defined in Section II-D.
TABLE III
CLASSIFICATION PERFORMANCES IN % USING THE α SET OF EXPONENTS
ESTIMATED OVER 4 OCTAVES
Center scale (s) Accuracy Sensitivity Specificity N. Feature
1.71 63.02 46.03 80.00 3
3.41 54.05 71.43 36.67 15
6.83 58.02 79.37 36.67 28
13.7 67.90 80.95 54.84 2
27.3 72.66 90.48 54.84 30
54.6 64.52 77.42 51.61 18
109.2 57.26 72.58 41.94 2
218.5 62.90 77.42 48.39 2
Bold indicates best accuracy set.
TABLE IV
CLASSIFICATION PERFORMANCES IN % USING THE β SET
Scale (s) Accuracy Sensitivity Specificity N. Feature
0.21 60.93 44.44 77.42 15
0.43 67.95 74.60 61.29 39
0.85 68.66 85.71 51.61 28
1.71 67.90 80.95 54.84 29
3.41 66.26 84.13 48.39 29
6.83 79.11 90.48 67.74 4
13.7 63.06 80.95 45.16 12
27.3 71.86 88.89 54.84 14
54.6 58.22 80.95 35.48 17
109 64.70 77.78 51.61 11
218 63.36 42.86 83.87 1
437 71.07 87.30 54.84 31
874 61.75 42.86 80.65 1
1748 67.13 76.19 58.06 21
3495 77.44 96.83 58.06 31
Bold indicates best accuracy per feature set.
Throughout the LOO-SVM procedure, prediction accuracy,
sensitivity and specificity in discerning SV vs. NS patients were
evaluated for feature sets α and β, whose results are shown in
Tables III and IV, respectively. For each scale, these tables report
the best classification accuracy using a proper combination of
features, as identified by the SVM-RFE algorithm. Considering
the two CHF classes, accuracy of 50% is the change.
Using the subset of exponents ζ (2), c1, c2, c3, c4, an accuracy
of 72.66% was obtained for exponents estimated over scales
27.3 s ± 2 octaves. Nevertheless, specificity was barely beyond
the chance level (54.84%), being therefore not suitable for an
actual clinical application.
Using the subset of multiscale representation log2 S(2, j),
C1( j),C2( j),C3( j),C4( j), best classification accuracy of
79.11% was obtained at scale 6.83 s, with satisfactory sensitivity
of 90.48% and specificity 67.74%. The trend of classification
accuracy as a function of the number of features is shown in
Fig. 4. Particularly, the following four features were selected as
best candidate for the prediction of survivors in patients with
CHF: log2 S(2, j),C3( j),C4( j) calculated over V L F(t), and
log2 S(2, j) calculated over L F/H F(t), at scale j = 10 (∼7 s)
at which the precise choice of interpolation (here, using the
informative point process model) has significant impact.
Fig. 4. Recognition accuracy in discerning NS vs. SV patients
as a function of the feature rank estimated through the SVM-
RFE procedure, considering feature set β comprising log2 S(2, j),
C1( j),C2( j),C3( j),C4( j) at scale 6.83 s.
Merging the proposed multifractal features of α and β sets
did not straightforwardly improve the aforementioned best clas-
sification accuracy of 79.11%.
IV. DISCUSSION AND CONCLUSION
We proposed a novel methodology combining multifractal
analysis with instantaneous (time resolution of 5 ms) physio-
logical estimates derived from inhomogeneous point-process
models of cardiovascular dynamics. As previous evidences
demonstrated that autonomic nervous system dynamics affects
heartbeat complexity at all scales [33], we hypothesized that
our methodology would provide a good predictor of mortality
following congestive heart failure with single-patient specific
prognostic capabilities.
All instantaneous series derived from our physiologically-
informative model show a clear scaling behaviour at coarser
scales over all indices of self-similarity and multifractality. Con-
versely, considering multifractal indices C2( j),C3( j),C4( j)
for the scales ∼2 − 10 s, the scaling behaviour of spline-
interpolated series of RR intervals is broken and departs from
the behaviour observed at scales ≥10 s. This is particularly
evident for multifractal index C4( j). Note that self-similar
models describe only parts of the scaling properties of the
heartbeat interval series, whereas multifractal models provide a
more comprehensive description (e.g., [2], [8]). Therefore, we
demonstrated that scaling and multiscale representations of RR
interval series is biased by the interpolating method employed
(e.g., linear, spline, etc.). Therefore, more informative ad-hoc
physiologically plausible models, such as the inhomogeneous
point-process [14], [25], are strongly recommended. This result
is in agreement with our previous investigations [14], [25]
demonstrating that the use of an inverse-Gaussian distribution,
characterized at each moment in time, inherits both physio-
logical (the integrate-and-fire initiating the cardiac contraction
[25]) and methodological information.
Additionally, we found that series of purely vagal dynamics,
i.e., H F(t), display power law scaling from ∼0.5 s to ∼82 s,
whereas series of sympatho-vagal dynamics (e.g., L F(t) and
L F/H F(t)) are associated with scale invariance in form of
power laws exclusively for scales larger than ∼100 s. This is
also in agreement with previous evidences reporting that sym-
pathetic activity affects complexity at long time scales [33] only.
Scaling and multifractal properties of circadian heartbeat dy-
namics in CHF patients, therefore, do not arise at a sinus-node
level, but seem to be already intrinsically present in vagal and
sympatho-vagal dynamics. At a speculative level, this can be due
to dysfunctional acetylcholine release on adrenergic receptors
on the vagal terminals, and/or dysfunctional cytosolic adeno-
sine 3,5-cyclic monophosphate release in post-junctions, and/or
dysfunctional acetylcholine release on muscarinic receptors [1].
Using these measures, we were able to predict survivor and
non-survivor CHF patients (4 year follow-up) with a satisfac-
tory accuracy of 79.11% (sensitivity 90.48% and specificity
67.74%), considering newly-derived heartbeat variables. To the
best of our knowledge, the majority of the previous studies
dealing with CHF mortality prediction evaluated the predictive
power of novel HRV markers using p-values and statistical in-
ference only. Since results from statistical inference refer to a
group-level analysis, whereas our classification results deal with
single subject-level analysis, a proper comparison of the pro-
posed multifractal point-process methodology with these stud-
ies cannot be performed. To give an idea of the significance of
our results, here we mention few studies that quantified accu-
racy, specificity, and sensitivity of an HRV- based methodology
for the mortality prediction in CHF. In particular, our results
show higher statistical performances than Yang et al. (accuracy:
74.4%) [34], Bigger et al. (sensitivity 58%, specificity of 71%)
[35], and are comparable with Pecchia et al. (79.3%) [36]. An
indirect quantitative reference to our results with other rele-
vant reports would point at an accuracy rate lower than Melillo
et al. (85.4%) [37], Guidi et al. (86%, sensitivity and sensibility
not reported) [38], and Shahbazi et al. (100%) [39], although
Melillo et al.’s method is with a specificity rate of 63.6%, and
results from Melillo et al., Guidi et al., and Shahbazi et al. are
from 41, 50, and 44 patients, respectively. Here, it is important
to highlight again that our study is associated with a signifi-
cantly higher statistical power than others, given our sample of
94 patients. Also, it must be noted that methods proposed by
Guidi et al. [38], and Yang et al. [34] need some parameters as
input that should be gathered directly from physicians, while the
adoption of only HRV measures, as in the current study, enables
a completely automatic assessment.
We found that optimal predictors of mortality in this kind
of pathology are associated with multifractal quantification of
very low frequency oscillations (<0.04 Hz) of heartbeat dy-
namics. Although precise physiological correlates of such VLF
are not well-defined yet [4], it is reasonable to associate proper
diagnostic and prognostic value to multifractal changes in car-
diovascular nonlinear oscillations with period between 25 s and
100 s. Accordingly, other studies involving circadian cardiovas-
cular rhythms or long-term sleep recordings highlighted such
clinical value of VLF dynamics, also as a powerful predictor
of clinical prognosis in patients with CHF [40]–[44]. In par-
ticular, testing on a large cohort of asymptomatic participants
undergoing 24 h Holter ECG recordings, the short-term fractal
scaling exponent of heartbeat dynamics and VLF power have
been recently selected as best candidate for the prediction of
CHF onset on follow-up [44]. To this extent, using the same
standard clinical recordings, our study makes a scientific step
forward, providing an effective methodology predicting mortal-
ity in CHF within a 4 years period at a single-patient level.
The number of subjects (94) has provided solid ground for
validation of our multifractal framework. Nevertheless, we are
planning a new prospective clinical trial study devoted to the
collection of long-term cardiovascular data from CHF patients,
including mortality follow-up evaluations. Moreover, we are
aware that the classification results shown in Tables III and IV
cannot be considered “optimal”. While in the initial phases of
this study we performed some exploratory analyses including
different classifiers such as Linear and Quadratic Discriminant
Classifiers, K-Nearest Neighbors, Artificial Neural Network,
and others, a rigorous/unbiased comparison between classifiers
would require proper parameter optimization to be performed at
each step of the leave one out procedure within a nested-cross
validation framework, which should also include parameter op-
timization for each classifier. This kind of optimization would
call for a larger sample size (see limitation above) and, most
importantly, is beyond the scope of this study, whose primary
aim is to demonstrate that novel multifractals for inhomoge-
neous point-process models carry very discriminant power and
are associated with prediction of CHF mortality. Indeed, the
obtained accuracy, with associated specificity and sensitivity,
may increase with a proper optimization of the classification
algorithm. Future works will also focus on the investigation of
combined scaling and multifractal analysis, and instantaneous
nonlinear/complex heartbeat dynamics including time-varying
bispectra [14], time-varying Lyapunov spectra [45], and time-
varying monovariate and multivariate cardiac entropy [16], [46],
extending therefore to higher-order statistics the recently pro-
posed complexity variability framework [45] (which is currently
defined through second-order moments).
In conclusion, this study poses a solid methodological basis
for devising a tool capable of performing accurate assessments
of CHF morbidity and sudden mortality, which still remain un-
acceptably high despite effective ongoing drug therapies. We
suggest that, in case of severe CHF, dysfunctional, multidi-
mensional power-law scaling of instantaneous sympatho-vagal
dynamics, as estimated through physiologically-plausible prob-
abilistic models of heartbeat generation, should be considered
as a high-mortality risk factor in a 4-year follow-up.
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